American Society of Hematology Announces 2013 Translational Research Training in Hematology Program Participants

2013-03-20

(WASHINGTON)-The American Society of Hematology (ASH) and the European Hematology Association (EHA) announce the names of 20 early-career hematologists chosen to participate in the 2013 Translational Research Training in Hematology (TRTH) joint program. The TRTH, now in its fourth year, provides junior researchers from around the world with a unique, yearlong training and mentoring experience with the goal of fostering the next generation of global leaders in the field of translational research.

Modeled after ASH’s successful Clinical Research Training Institute (CRTI), the TRTH program began with a rigorous one-week training course held March 15 to 21, 2013, in Milan, Italy. During the weeklong course, participants attend didactic and interactive sessions led by some of the world’s leading hematology and translational researchers serving as TRTH faculty on translational research methodology and regulatory requirements. Trainees also participate in small-group sessions with their TRTH peers and faculty to refine individual research proposals and attend informal presentations by leaders in hematology that are designed to illustrate the variety of pathways to a successful career in hematology research through personal experience.

After the initial weeklong course, participants will meet again at the EHA annual congress in June and again at the ASH annual meeting in December to review the progress of their projects.

The TRTH program not only teaches the basics of research methodology, epidemiology, and biostatistics, but it also allows participants to gain hands-on experience in these disciplines, while at the same time providing a network of peers and mentors that will be a source of support in the years to come.

TRTH program participants include medical trainees, biomedical trainees, and pharmaceutical doctorate trainees who are within 12 years of receiving their medical degrees or who have less than eight years of postdoctoral experience. Trainees must be members of either ASH or EHA.

2013 TRTH Participants

Heiko Becker, MD
University Freiburg Medical Center
Freiburg, Germany

Amit Bhat, MD, PhD
Oxford University
Oxford, United Kingdom

Conrad Russell Cruz, MD, PhD
University of Minnesota Medical School
Minneapolis, MN

Ann-Kathrin Esfeld, MD
The Ohio State University Comprehensive Cancer Center
Columbus, OH

Caroline Furness, MD
Institute of Cancer Research
London, United Kingdom

Charles Gawad, MD
Stanford University
Stanford, CA

Patrick Hanley, PhD
Baylor College of Medicine
Houston, TX

Maria Kleppe, PhD
Memorial Sloan-Kettering Cancer Center
New York, NY

Goldi A. Kozloski, PhD
University of Miami Miller School of Medicine
Miami, FL

Moira Michelle Lancelot, MD
Dana-Farber Cancer Institute
Boston, MA

Onima Chowdury, MD
Children's Hospital of Michigan
Detroit, MI

Fabienne McClanahan, MD
Barts Cancer Institute
London, United Kingdom

Klaus Metzler, MD
University of Munich, University College
Groβhadern
Groβhadern, Germany

Teresa Mortera-Blanco, PhD
Karolinska Institutet
Stockholm, Sweden

Daniel Pollyea, MD
University of Colorado
Boulder, CO

Lindsay Anne Rein, MD
Duke University Medical Center
Durham, NC

Jamshid Sorouri Khorashad, MD, PhD
The University of Utah Huntsman Cancer Institute
Salt Lake City, UT

Frank Stegemann, MD
University Hospital of Ulm
Ulm, Germany

David Sykes, MD, PhD
Massachusetts General Hospital
Boston, MA

To arrange an interview with a TRTH participant, please contact Andrea Slesinski, ASH Communications Manager, at 202-552-4927 or aslesinski@hematology.org. 

The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.

back to top